Compare Pfizer with FDC LTD. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs FDC LTD. - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER FDC LTD. PFIZER/
FDC LTD.
 
P/E (TTM) x 37.8 16.3 231.8% View Chart
P/BV x 6.5 2.8 228.2% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 PFIZER   FDC LTD.
EQUITY SHARE DATA
    PFIZER
Mar-19
FDC LTD.
Mar-18
PFIZER/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs3,840319 1,203.8%   
Low Rs2,080164 1,268.3%   
Sales per share (Unadj.) Rs455.061.6 738.1%  
Earnings per share (Unadj.) Rs93.89.9 942.6%  
Cash flow per share (Unadj.) Rs109.412.0 914.3%  
Dividends per share (Unadj.) Rs22.500-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs658.273.2 899.6%  
Shares outstanding (eoy) m45.75174.40 26.2%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x6.53.9 166.1%   
Avg P/E ratio x31.624.3 130.0%  
P/CF ratio (eoy) x27.120.2 134.1%  
Price / Book Value ratio x4.53.3 136.3%  
Dividend payout %24.00-   
Avg Mkt Cap Rs m135,42042,118 321.5%   
No. of employees `0002.65.5 47.6%   
Total wages/salary Rs m3,2382,167 149.5%   
Avg. sales/employee Rs Th7,911.41,943.7 407.0%   
Avg. wages/employee Rs Th1,230.9391.7 314.2%   
Avg. net profit/employee Rs Th1,630.7313.7 519.8%   
INCOME DATA
Net Sales Rs m20,81510,751 193.6%  
Other income Rs m1,674510 328.5%   
Total revenues Rs m22,48911,260 199.7%   
Gross profit Rs m5,7122,267 252.0%  
Depreciation Rs m714351 203.2%   
Interest Rs m7314 520.7%   
Profit before tax Rs m6,5992,411 273.7%   
Minority Interest Rs m0-5 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,309671 344.0%   
Profit after tax Rs m4,2911,735 247.3%  
Gross profit margin %27.421.1 130.1%  
Effective tax rate %35.027.8 125.7%   
Net profit margin %20.616.1 127.7%  
BALANCE SHEET DATA
Current assets Rs m27,1677,213 376.7%   
Current liabilities Rs m8,9172,104 423.9%   
Net working cap to sales %87.747.5 184.5%  
Current ratio x3.03.4 88.9%  
Inventory Days Days6854 124.4%  
Debtors Days Days3028 108.6%  
Net fixed assets Rs m8,8626,865 129.1%   
Share capital Rs m458175 261.1%   
"Free" reserves Rs m29,65612,586 235.6%   
Net worth Rs m30,11312,761 236.0%   
Long term debt Rs m256 416.7%   
Total assets Rs m39,40015,041 261.9%  
Interest coverage x91.5173.2 52.8%   
Debt to equity ratio x00 176.6%  
Sales to assets ratio x0.50.7 73.9%   
Return on assets %11.111.6 95.2%  
Return on equity %14.213.6 104.8%  
Return on capital %22.119.0 116.8%  
Exports to sales %012.3 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA1,327 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m4281,889 22.7%   
Fx outflow Rs m7860-   
Net fx Rs m-3581,889 -19.0%   
CASH FLOW
From Operations Rs m9781,498 65.3%  
From Investments Rs m351201 174.6%  
From Financial Activity Rs m-1,099-1,694 64.8%  
Net Cashflow Rs m23110 2,240.8%  

Share Holding

Indian Promoters % 0.0 68.9 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 4.7 159.6%  
FIIs % 4.9 7.5 65.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 19.0 124.7%  
Shareholders   85,207 23,730 359.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   DR. REDDYS LAB  STERLING BIOTECH  JUBILANT LIFE SCIENCES  AUROBINDO PHARMA  IPCA LABS  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Zooms 2,476 Points; Banking, Energy and Automobile Stocks Rally(Closing)

Indian share markets continued to trade in the green during closing hours and ended their day on a strong note.

Related Views on News

PFIZER Surges by 7%; BSE HEALTHCARE Index Up 7.4% (Market Updates)

Apr 7, 2020 | Updated on Apr 7, 2020

PFIZER share price has surged by 7% and its current market price is Rs 4,340. The BSE HEALTHCARE is up by 7.4%. The top gainers in the BSE HEALTHCARE Index are PFIZER (up 7.0%) and SANOFI INDIA (up 5.4%). The top losers are GSK PHARMA (down 2.0%) and PIRAMAL ENTERPRISES (down 2.1%).

PFIZER Surges by 7%; BSE HEALTHCARE Index Up 5.3% (Market Updates)

Apr 7, 2020 | Updated on Apr 7, 2020

PFIZER share price has surged by 7% and its current market price is Rs 4,340. The BSE HEALTHCARE is up by 5.3%. The top gainers in the BSE HEALTHCARE Index are PFIZER (up 6.7%) and SANOFI INDIA (up 6.0%). The top losers is GSK PHARMA (down 0.4%).

PFIZER Announces Quarterly Results (3QFY20); Net Profit Up 5.4% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, PFIZER has posted a net profit of Rs 1 bn (up 5.4% YoY). Sales on the other hand came in at Rs 5 bn (up 4.7% YoY). Read on for a complete analysis of PFIZER's quarterly results.

FDC LTD. Announces Quarterly Results (3QFY20); Net Profit Up 67.7% (Quarterly Result Update)

Feb 10, 2020 | Updated on Feb 10, 2020

For the quarter ended December 2019, FDC LTD. has posted a net profit of Rs 733 m (up 67.7% YoY). Sales on the other hand came in at Rs 3 bn (up 26.0% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (2QFY20); Net Profit Up 45.4% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, FDC LTD. has posted a net profit of Rs 627 m (up 45.4% YoY). Sales on the other hand came in at Rs 3 bn (up 28.8% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

More Views on News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020(The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

One Stock that is All Charged Up for the Post Coronavirus Rebound(The 5 Minute Wrapup)

Apr 1, 2020

A stock with strong moat is currently trading near 5-year lows.

A Big Trading Opportunity is Coming Your Way Soon(Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

The Insiders See a Buying Opportunity in These Smallcaps Amid Coronavirus Outbreak(Profit Hunter)

Mar 31, 2020

The promoters are buying these smallcaps amid the coronavirus outbreak.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Apr 7, 2020 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS